| Trial ID: | L0078 |
| Source ID: | NCT01208649
|
| Associated Drug: |
Exenatide
|
| Title: |
Effects of Exenatide (Byetta??) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Exenatide
|
| Outcome Measures: |
histological activity of NASH (steatosis, necroinflammation, ballooning)|Liver fibrosis, as determined using the fibrosis score
|
| Sponsor/Collaborators: |
Ruhr University of Bochum
|
| Gender: |
All
|
| Age: |
18 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
13
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
July 2008
|
| Completion Date: |
September 2010
|
| Results First Posted: |
--
|
| Last Update Posted: |
September 24, 2010
|
| Locations: |
Department of Medicine I; University Hospital St. Josef-Hospital, Bochum, Germany
|
| URL: |
https://ClinicalTrials.gov/show/NCT01208649
|
